Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

NOVO NORDISK LDA

NIF 501485210
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €3,852,692 33 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €3,852,692 33 contracts
A2 · Late Publication €2,089,402,698 891 contracts
Contract published to BASE more than 10 days after the signing date
LOW €2,089,402,698 891 contracts
A5 · Threshold Splitting €2,512,004 40 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €2,512,004 40 contracts
A6 · Low Competition €10,106,432 18 contracts
Only one bidder participated in a competitive procedure
MEDIUM €10,106,432 18 contracts
A9 · Abnormal Price Reduction €2,203,588,943 367 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €2,203,588,943 367 contracts
C3 · Missing Mandatory Fields €568,662 17 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €568,662 17 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

12
€333,693,786
95
€312,802,766
11
€312,191,259
23
€295,288,418
44
€264,985,819
115
€241,548,802
13
€232,828,498
10
€111,564,075
13
€52,365,717
201
€51,090,226
39
€17,890,538
7
€15,628,029
78
€9,649,095
16
€3,765,575
7
€3,681,621
14
€3,143,927
70
€3,021,880
53
€2,343,830
66
€1,827,767
39
€1,806,851
Page 1 of 4 · 63 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Abnormal Price Reduction C3 · Missing Mandatory Fields

Page 1 of 1 · 40 contracts

ANTI-HEMORRAGICOS - TUROCTOCOG ALFA PEGOL
PT · 12007603 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€72,736 2025-12-03
41/188/2026 - Medic. do Aparelho locomotor. empregues na terapêutica das doenças endócrinas e hormonas
PT · 12688568 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€19,777 2025-11-06
MEDICAMENTOS
PT · 11313268 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€19,131 2025-02-21
MEDICAMENTOS
PT · 11130355 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€74,145 2024-12-18
FACTOR IX 500UI LONGA DURACAO NONACOG BETA PEGOL FRS (PC.02275.2024)
PT · 10887939 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€72,235 2024-07-26
FACTOR IX 500UI LONGA DURACAO NONACOG BETA PEGOL FRS (PC.01555.2024)
PT · 10730498 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€72,235 2024-05-16
Eptacog alfa inj. 100 kui/2ml _ 250 kui/5ml fr/amp.
PT · 11316279 · Ajuste Direto Regime G...
A5 · Threshold Splitting A1 · Repeat Direct Award +1
€19,726 2024-04-24
Aquisição de Medicamentos de uso humano
PT · 10663343 · Ajuste Direto Regime G...
A5 · Threshold Splitting A1 · Repeat Direct Award +1
€73,865 2024-04-02
PA 82/PA/HPSJD/2024- Aquisição de bens para os Serviços Farmacêuticos do Hospital Prisional em 2024.
PT · 10597136 · Consulta Prévia
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€74,962 2024-02-28
TUROCTOCOG ALFA PEGOL
PT · 10408283 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€74,537 2023-12-27
FACTOR IX 500UI LONGA DURACAO NONACOG BETA PEGOL FRS (PC.1807.2023)
PT · 10435875 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€72,235 2023-12-19
Aquisição de NONAcog beta pegol 2000 U.I. Pó sol inj Fr IV
PT · 10204776 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€144,468 2023-08-17
FACTOR IX 500UI LONGA DURAÇÃO NONACOG BETA PEGOL FRS
PT · 9980528 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€144,470 2023-04-21
Aquisição de medicamentos do aparelho locomotor usados no tratamento das doenças endócrinas e hormonas - CPA 2021/47
PT · 10076848 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€149,243 2023-03-07
AQUISIÇÃO DE FATOR VIII RECOMBINANTE COAGULAÇÃO DE SEMIVIDA PROLONGADA
PT · 9408344 · Consulta Prévia
A5 · Threshold Splitting A2 · Late Publication
€72,000 2022-07-07
factor ix 500ui longa duração
PT · 9623193 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€72,235 2022-05-27
AQUISIÇÃO DE MEDICAMENTOS DO APARELHO LOCOMOTOR, USADOS NAS DOENÇAS ENDÓCRINAS E HORMONAS, AO ABRIGO DO ACORDO QUADRO 2021/047 DOS SPMS, EPE
PT · 9324996 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€74,554 2021-11-16
Q1/2462/2021-Medicamentos do aparelho locomotor, usados no tratamento das doenças endócrinas e hormonas
PT · 7814157 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€145,203 2021-08-11
Aquisição de 350 frascos de Glucagom
PT · 7752582 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€4,777 2021-06-24
Aquisição de 350 frascos de Glucagom
PT · efbb5195da5786457806 · Ao abrigo de acordo-qu...
A2 · Late Publication A5 · Threshold Splitting
€4,777 2021-06-24
Aquisição de hormonas e outros medicamentos usados no tratamento de doenças endócrinas
PT · 8402860 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€4,777 2021-04-13
Aprov/PRT 21001061 - AP 561
PT · 7606467 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€4,777 2021-04-12
TUROCTOCOG ALFA
PT · 7690585 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€71,796 2021-02-11
SOMATROPINA 10 MG/1.5 ML SOL INJ CANETA 1.5 ML SC
PT · 7598069 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,906 2020-12-15
TUROCTOCOG ALFA 1500
PT · 7632477 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€71,796 2020-09-29
AQUISIÇÃO DE MEDICAMENTOS PARA SUPRIR NECESSIDADES NO ÂMBITO DO CONTEXTO EPIDEMIOLÓGICO DA DOENÇA RESPIRATÓRIA AGUDA POR NOVO CORONAVÍRUS (2019-NCOV) - INÍCIO DE PROCEDIMENTO
PT · 6509084 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€72,255 2020-04-14
FACTOR VII REC.SOL INJ 1 MG e FACTOR VII REC. SOL INJ 2 MG
PT · 4695457 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€145,382 2018-04-19
Aquisição de insulina neutra sol. inj. frs/amp. 10 ml
PT · 4413911 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€4,962 2018-04-17
181000328 - INSULINA NEUTRA SOL INJ FRS/AMP 10 ML
PT · 5000381 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€4,962 2018-02-08
MEDICAMENTOS E HORMONAS HIPOTÁLAMO E HIPÓFISE SOMATROPINA 1º SEM 2018
PT · 4335435 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€19,027 2018-01-24
INSULINAS
PT · 4565811 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,190 2018-01-18
Hormonas e Outros Medicamentos Doenças Endocrinas para a ULSNA , EPE em 2017
PT · 3908009 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€71,663 2017-07-25
Fornecimento de hormonas e outros medicamentos usados no tratamento de doenças endócrinas ao abrigo do CPA 2015/007
PT · 4424391 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€74,488 2017-06-19
Aquisição de fator VII recombinante sol. inj. 5 mg
PT · 3958625 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€145,041 2017-03-20
MEDICAMENTOS USADOS DOENÇAS ENDÓCRINAS
PT · 2955066 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€71,820 2017-01-19
AD para Aquisição de Somatropina 10mg/1.5ML Sol inj Cartuxo 1.5 ML SC (CPA2015/07)
PT · 2253144 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€4,820 2016-06-16
Aquisição - Eptacog alfa (activado), para o Hospital Divino Espírito Santo de Ponta Delgada, EPER
PT · 2252246 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€19,616 2016-05-12
HIPOTÁLAMO E HIPOFISE PARA 2016
PT · 2611475 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€148,471 2016-04-28
AD/140/2013 - Aquisição de Medicamentos Diversos
PT · 841749 · Ajuste Direto Regime G...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€74,999 2013-09-30
Aquisição de insulina
PT · a44d750e9dc2384a3e1a · Ajuste direto
A5 · Threshold Splitting A1 · Repeat Direct Award
€4,944 2013-08-12
Overview
Total Value Won
€2,290,120,415
Contracts Won
1,332
Score 43060 · CRITICAL RISK
NIF
501485210
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • A.A. [P-8553]
    Gerente
    since 2009-02-09
  • E.F. [P-77ad]
    Gerente
    since 2013-03-06
  • E.F. [P-77ad]
    Gerente
    since 2017-05-09
  • F.K. [P-9e9a]
    Gerente
    since 2020-11-13
  • J.B. [P-5563]
    Gerente
    since 2026-04-01
  • J.R. [P-56e9]
    Gerente
    since 2014-12-17
  • J.E. [P-de96]
    Gerente
    since 2022-12-09
  • L.S. [P-9552]
    Gerente
    since 2008-07-22
  • M.V. [P-d275]
    Gerente
    since 2020-11-13
  • M.H. [P-b191]
    Gerente
    since 2013-03-06
  • O.F. [P-bd10]
    Gerente
    since 2009-02-09
  • O.F. [P-bd10]
    Gerente
    since 2013-03-06
  • O.F. [P-bd10]
    Gerente
    since 2017-05-09
  • T.H. [P-b80c]
    Gerente
    since 2019-03-12
  • E.F. [P-77ad]
    Gerente
    2018-02-09 → 2020-11-13
  • F.K. [P-9e9a]
    Gerente
    2021-04-20 → 2022-12-09
  • L.S. [P-9552]
    Gerente
    until 2010-07-31
  • M.V. [P-d275]
    Gerente
    2021-04-20 → 2026-04-01
  • M.E. [P-8501]
    Gerente
    2024-03-04 → 2026-04-01
  • M.H. [P-b191]
    Gerente
    until 2009-02-09
  • M.H. [P-b191]
    Gerente
    2010-07-31 → 2014-12-17
  • M.J. [P-4504]
    Gerente
    2018-02-09 → 2020-11-13
  • O.F. [P-bd10]
    Gerente
    2018-02-09 → 2019-03-12
  • T.H. [P-b80c]
    Gerente
    2021-04-20 → 2024-03-04
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned